DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roerig, D. L.
Right arrow Articles by Wang, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roerig, D. L.
Right arrow Articles by Wang, R. I.

Uptake of l-alpha-acetylmethadol (LAAM) and its analgesically active metabolites, nor-LAAM and dinor-LAAM, in the isolated perfused rat lung

DL Roerig, RR Dahl, CA Dawson and RI Wang

The pulmonary uptake of l-alpha-acetylmethadol (LAAM) and its major analgesically active metabolites, nor-LAAM and dinor-LAAM, was studied during a single pass through the isolated perfused rat lung (IPL). The radiolabeled drugs were infused into the IPL for 10 min followed by a 30-min drug-free perfusion. All three drugs were extensively taken up into the IPL; however, dinor-LAAM, the least lipophilic, accumulated to the greatest extent. Their rates of efflux from the IPL with time could be described by the sum of three exponentials and 20-25% of each compound accumulated in a "slowly effluxable pool," suggesting a highly sequestered pool of drug in the lung. These findings suggest that tissue sequestration of the active metabolites is equal to or greater than LAAM itself. Such tissue sequestration could limit the sequential metabolic activation or inactivation, and serve as a reservoir of the active compounds. These factors favor the persistence of LAAM and its active metabolites in the body, thus prolonging the opiate-like effects after LAAM administration. The data also indicated that the relationship between drug basicity or lipophilicity and extent of uptake is complex and it is difficult to associate a particular physicochemical property with the extent or character of pulmonary drug uptake.

Volume 11, Issue 5, pp. 411-416, 09/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
D. L. Roerig, S. H. Audi, and S. B. Ahlf
KINETIC CHARACTERIZATION OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF RHODAMINE 6G IN THE INTACT RABBIT LUNG
Drug Metab. Dispos., September 1, 2004; 32(9): 953 - 958.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. M. Waters, M. J. Avram, T. C. Krejcie, and T. K. Henthorn
Uptake of Fentanyl in Pulmonary Endothelium
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 157 - 163.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
S. H. Audi, C. A. Dawson, J. H. Linehan, G. S. Krenz, S. B. Ahlf, and D. L. Roerig
Pulmonary disposition of lipophilic amine compounds in the isolated perfused rabbit lung
J Appl Physiol, February 1, 1998; 84(2): 516 - 530.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.